TFC Financial Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Hold |
278
| – | – | ﹤0.01% | 308 |
|
|
2025
Q1 | $28K | Hold |
278
| – | – | ﹤0.01% | 295 |
|
|
2024
Q4 | $24.8K | Buy |
278
+210
| +309% | +$18.8K | ﹤0.01% | 295 |
|
|
2024
Q3 | $5.7K | Sell |
68
-1,500
| -96% | -$126K | ﹤0.01% | 404 |
|
|
2024
Q2 | $121K | Hold |
1,568
| – | – | 0.02% | 156 |
|
|
2024
Q1 | $107K | Buy |
1,568
+7
| +0.4% | +$479 | 0.02% | 170 |
|
|
2023
Q4 | $90.2K | Sell |
1,561
-9
| -0.6% | -$520 | 0.02% | 180 |
|
|
2023
Q3 | $82.9K | Sell |
1,570
-9
| -0.6% | -$475 | 0.02% | 179 |
|
|
2023
Q2 | $85.4K | Buy |
1,579
+18
| +1% | +$974 | 0.02% | 181 |
|
|
2023
Q1 | $78.1K | Buy |
1,561
+22
| +1% | +$1.1K | 0.02% | 188 |
|
|
2022
Q4 | $71.2K | Hold |
1,539
| – | – | 0.02% | 180 |
|
|
2022
Q3 | $60K | Hold |
1,539
| – | – | 0.02% | 186 |
|
|
2022
Q2 | $57K | Hold |
1,539
| – | – | 0.02% | 194 |
|
|
2022
Q1 | $68K | Hold |
1,539
| – | – | 0.02% | 186 |
|
|
2021
Q4 | $65K | Hold |
1,539
| – | – | 0.02% | 196 |
|
|
2021
Q3 | $67K | Hold |
1,539
| – | – | 0.02% | 189 |
|
|
2021
Q2 | $66K | Hold |
1,539
| – | – | 0.02% | 181 |
|
|
2021
Q1 | $59K | Hold |
1,539
| – | – | 0.02% | 184 |
|
|
2020
Q4 | $55K | Hold |
1,539
| – | – | 0.02% | 187 |
|
|
2020
Q3 | $59K | Buy |
+1,539
| New | +$59K | 0.03% | 164 |
|